“PED/PEA-15 regulates wound healing and angiogenesis by affecting cytoskeletal organization and cell motility: a model for diabetic complications” by Buonomo, Roberta
 Doctorate Program in Molecular 
Oncology and Endocrinology 
Doctorate School in Molecular 
Medicine 
 
XXIII cycle - 2007–2010 
Coordinator: Prof. Giancarlo Vecchio 
 
 
 
 
“PED/PEA-15 regulates wound healing and angiogenesis by 
affecting cytoskeletal organization and cell motility: a model 
for diabetic complications” 
 
Roberta Buonomo 
 
 
 
 
University of Naples Federico II 
Dipartimento di Biologia e Patologia Cellulare e Molecolare 
“L. Califano” 
Administrative Location 
 
Dipartimento di Biologia e Patologia Cellulare e Molecolare “L. Califano” 
Università degli Studi di Napoli Federico II 
 
Partner Institutions 
 
Italian Institutions 
Università degli Studi di Napoli “Federico II”, Naples, Italy 
Istituto di Endocrinologia ed Oncologia Sperimentale “G. Salvatore”, CNR, Naples, Italy 
Seconda Università di Napoli, Naples, Italy 
Università degli Studi di Napoli “Parthenope”, Naples, Italy 
Università del Sannio, Benevento, Italy 
Università di Genova, Genoa, Italy 
Università di Padova, Padua, Italy 
Università degli Studi “Magna Graecia”, Catanzaro, Italy 
Università degli Studi di Firenze, Florence, Italy 
Università degli Studi di Bologna, Bologna, Italy 
Università degli Studi del Molise, Campobasso, Italy 
Università degli Studi di Torino, Turin, Italy 
Università di Udine, Udine, Italy 
 
Foreign Institutions 
Université Libre de Bruxelles, Brussels, Belgium 
Universidade Federal de Sao Paulo, Brazil 
University of Turku, Turku, Finland 
Université Paris Sud XI, Paris, France 
University of Madras, Chennai, India  
University Pavol Jozef Šafàrik, Kosice, Slovakia 
Universidad Autonoma de Madrid, Centro de Investigaciones Oncologicas (CNIO), Spain  
Johns Hopkins School of Medicine, Baltimore, MD, USA 
Johns Hopkins Krieger School of Arts and Sciences, Baltimore, MD, USA 
National Institutes of Health, Bethesda, MD, USA 
Ohio State University, Columbus, OH, USA 
Albert Einstein College of Medicine of Yeshiwa University, N.Y., USA 
 
Supporting Institutions 
Associazione Leonardo di Capua, Naples, Italy 
Dipartimento di Biologia e Patologia Cellulare e Molecolare “L. Califano”, Università degli Studi di 
Napoli “Federico II”, Naples, Italy 
Istituto Superiore di Oncologia (ISO), Genoa, Italy  
Istituto di Endocrinologia ed Oncologia Sperimentale “G. Salvatore”, CNR, Naples, Italy 
Italian Faculty 
 
 
 
Giancarlo Vecchio, MD, Co-ordinator 
Salvatore Maria Aloj, MD 
Francesco Saverio Ambesi Impiombato, MD 
Francesco Beguinot, MD 
Maria Teresa Berlingieri, MD 
Bernadette Biondi, MD 
Francesca Carlomagno, MD 
Gabriella Castoria, MD 
Angela Celetti, MD 
Lorenzo Chiariotti, MD 
Vincenzo Ciminale, MD  
Annamaria Cirafici, PhD 
Annamaria Colao, MD 
Sabino De Placido, MD 
Gabriella De Vita, MD 
Monica Fedele, PhD  
Pietro Formisano, MD 
Alfredo Fusco, MD 
Michele Grieco, MD 
Massimo Imbriaco, MD 
Paolo Laccetti, PhD 
Antonio Leonardi, MD 
Paolo Emidio Macchia, MD 
Barbara Majello, PhD 
Rosa Marina Melillo, MD 
Claudia Miele, PhD 
Roberto Pacelli, MD 
Giuseppe Palumbo, PhD 
Silvio Parodi, MD 
Nicola Perrotti, MD 
Giuseppe Portella, MD 
Giorgio Punzo, MD 
Antonio Rosato, MD 
Guido Rossi, MD 
Giuliana Salvatore MD 
Massimo Santoro, MD 
Giampaolo Tortora, MD 
Donatella Tramontano, PhD 
Giancarlo Troncone, MD 
Giuseppe Viglietto, MD 
Mario Vitale, MD 
 
 
 
 
 
Foreign Faculty 
 
 
Université Libre de Bruxelles, Belgium 
Gilbert Vassart, MD 
Jacques E. Dumont, MD 
 
Universidade Federal de Sao Paulo, Brazil 
Janete Maria Cerutti, PhD 
Rui Monteiro de Barros Maciel, MD PhD 
 
University of Turku, Turku, Finland 
Mikko Laukkanen, PhD 
 
Université Paris Sud XI, Paris, France 
Martin Schlumberger, MD 
Jean Michel Bidart, MD 
 
University of Madras, Chennai, India  
Arasambattu K. Munirajan, PhD 
 
University Pavol Jozef Šafàrik, Kosice, 
Slovakia 
Eva Cellárová, PhD 
Peter Fedoročko, PhD 
 
Universidad Autonoma de Madrid - Instituto 
de Investigaciones Biomedicas, Spain 
Juan Bernal, MD, PhD 
Pilar Santisteban, PhD 
 
Centro de Investigaciones Oncologicas, Spain 
Mariano Barbacid, MD 
 
Johns Hopkins School of Medicine, USA 
Vincenzo Casolaro, MD 
Pierre A. Coulombe, PhD 
James G. Herman MD 
Robert P. Schleimer, PhD 
 
Johns Hopkins Krieger School of Arts and 
Sciences, USA 
Eaton E. Lattman, MD 
 
National Institutes of Health, Bethesda, MD, 
USA 
Michael M. Gottesman, MD 
J. Silvio Gutkind, PhD 
Genoveffa Franchini, MD 
Stephen J. Marx, MD 
Ira Pastan, MD 
Phillip Gorden, MD 
 
Ohio State University, Columbus, OH, USA 
Carlo M. Croce, MD 
Ginny L. Bumgardner, MD PhD 
 
Albert Einstein College of Medicine of Yeshiwa 
University, N.Y., USA 
Luciano D’Adamio, MD 
Nancy Carrasco, MD 
 
 
   
 
 
 
 
 
 
 
“PED/PEA-15 regulates wound 
healing and angiogenesis by 
affecting cytoskeletal 
organization and cell motility: a 
model for diabetic 
complications” 
 
 1  
TABLE OF CONTENTS 
 
1. BACKGROUND …...……………………………………………………………………..4 
 1.1    Diabetes………………………………………………………………………………..4 
 1.1.2 Type 1 Diabetes Mellitus……….……………………………………………………...4 
 1.1.3 Type 2 Diabetes Mellitus……….……………………………………………………...5 
 1.1.4 Metabolic abnormalities………….……………………………………………………5 
 1.2 Genetic consideration……………………………………………………………………6 
 1.3 Hyperglycemia and diabetic complication………………………………...…………….7 
 1.4 Diabetic foot……………………………………………………………………………..8 
 1.4.1 Wound healing physiology…………………………………………………………….8 
 1.5 Molecular mechanism of wound healing……………………………………………….10 
 1.5.1 Cell proliferation……………………………………………………………………...10 
 RAS/MAPK pathway……………………………………………………………….10 
 PKCS’ pathway……………………………………………………………………..11 
 PI3K/PKB pathway…………………………………………………………….........12 
           1.5.2 Cell migration…………   …………………………………………………………….12 
 JNK signalling……………………………………………………………………......14 
 p38 signaling…………………………………………………………………………15 
 ERK/MAPK signalling………………………………………………………………15 
            1.6 Wound healing in diabetes……………………………………………….……………16 
            1.6.1 The inflammatory component of diabetic wound healing……………………………17 
            1.6.2 Fibroblasts dysfunction in diabetes…………………………………………………..19 
               
2. AIM OF THE STUDY………………………………………………………………….20 
 
3. MATHERIALS AND METHODS………………………………………………....…..21 
 
4. RESULTS AND DISCUSSION…………………………………………………….......27 
4.1 Ped/Pea-15 effect on wound healing in vivo……………………………………………27 
4.2  In vivo evaluation of mice inflammatory state ………………………………………...27 
4.3  Assessment of angiogenetic resonse in mice skin……………………………………...28 
4.4  Effect of  Ped/Pea-15 on endothelial cells migration and tube formation …………….28 
4.5  Effect of  Ped/Pea-15 on fibroblasts involved in the wound healing ………………….30 
4.6  Direct evaluation of fibroblast motility by time-lapse microscopy (TLM)……………32 
4.7  Ped/Pea-15 effect on cell adhesion, spreading and cytoskeleton organization………...34 
4.8  Ped/Pea-15 effect on RhoA activity and subcellular distribution……………………. .35 
4.9  Ped/Pea-15 effect on ERK1/2 activation and function in wound healing alteration…. .36 
4.10  Ped/Pea-15 depletion increased fibroblast, spreading and wound closure…………....40 
 
5    CONCLUSIONS................................................................................................................42 
        
       6.   ACKNOWLEDGMENTS.................................................................................................44 
       
      7.    REFERENCES..................................................................................................................45 
 
 
 2  
LIST OF PUBLICATIONS 
 
This dissertation is based upon the following publications: 
 
Roberta Buonomo*1,2, Ferdinando Giacco*1,2, Angela Vasaturo3, Stefano Guido3, 
Corrado Garbi1, Valentina Pagliara1, Gelsomina Mansueto4, Angela Cassese1,2, 
Giuseppe Perruolo1,2, Francesco Oriente1, Claudia Miele1,2, Francesco Beguinot1,2, 
Pietro Formisano1,2. 
Phosphoprotein enriched in diabetes/phosphoprotein enriched in astrocytes-15 
controls fibrobast migration and wound closure by an extracellular signal-
regulated kinase 1/2-dependent mechanism 
The Journal of  Biological Chemistry, Pending revision 
 
R. Buonomo, A. Cassese, F. Giacco, G. Raciti, Claudia Miele, Pietro Formisano, 
Francesco Beguinot 
Ped/pea-15 ablation in vivo ameliorates glucose stimulated insulin secretion and 
increases glucose tolerance in mice  
Manuscript in preparation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3  
ABSTRACT 
 
 
Failure in wound healing is a common feature of diabetes mellitus which severely 
affects morbidity and mortality. We evaluated wound healing in the skin of 
transgenic mice (TgPED) over-expressing ped/pea-15, a gene over-expressed in 
patients with type 2 diabetes.Up to four days after the injury, the distance between 
wound edges was 3-fold higher in TgPED mice compared to their wild-type 
littermates (Wt). TgPED mice also presented significantly reduced granulation 
tissue formation as compared to Wt. Moreover, the wounded skin of TgPED 
exhibited also a reduced content of activated fibroblasts, collagen fibres and an 
increased detection of infiltrated inflammatory cells. These histological alterations 
were accompanied, in TgPED speciments, by an increased production of 
inflammatory cytokines and a defect of neo-angiogenesis process. Then we 
isolated endothelial cells and fibroblasts from TgPED and Wt mice, mainly 
involved in the formation of the granulation tissue, the first regenerative tissue that 
closes the skin gap. Endothelial cells and skin fibroblasts isolated from TgPED 
and Wt mice showed reduced healing ability in scratch wound healing assays 
compared to control cells. Furthermore, in time-lapse experiments, TgPED 
fibroblasts displayed about 2-fold lower velocity and diffusion coefficient, as 
compared with Wt. These changes were accompanied by reduced spreading and 
decreased formation of stress fibres and focal adhesion plaques. At molecular 
level, TgPED fibroblasts displayed decreased RhoA membrane content and 
increased cytosolic abundance of phosphorylated ERK1/2. Inhibition of ERK1/2 
activity by PD98059 restored RhoA membrane translocation, cytoskeleton 
organization and cell motility and almost completely rescued wound healing 
ability of TgPED fibroblasts and can be expanded to endothelial cells. 
Interestingly, fibroblasts isolated from ped/pea-15 null mice (KO) displayed an 
increased motility and spreading compared to control cells. These results strongly 
support a role of PED/PEA-15 in the regulation of cell motility during skin wound 
healing. Moreover, the control exerted by PED/PEA-15 on cell migration is not 
restricted to fibroblasts. Considering the different known cellular function of 
PED/PEA-15 in a chronic disorder such as diabetes, the observation that 
PED/PEA-15 regulates cellular motility and skin wound healing in TgPED mice 
may suggest these mice as model to study the role of PED/PEA-15 in diabetic 
complications.  
 
 
 
 
 
 4  
1. BACKGROUND 
 
1.1 Diabetes  
 
Diabetes mellitus (DM) comprises a group of common metabolic disorders that 
share the phenotype of hyperglycemia. Several distinct types of DM exist and are 
caused by a complex interaction of genetic and environmental factors, and life-
style choices. Depending on the etiology of the DM, factors contributing to 
hyperglycemia may include reduced insulin secretion, decreased glucose 
utilization, and increased glucose production. The metabolic dysregulation 
associated with DM causes secondary pathophysiologic changes in multiple organ 
systems that impose a tremendous burden on the individual with diabetes and on 
the health care system. DM is classified on the basis of the pathogenic process that 
leads to hyperglycemia. The two broad categories of DM are designated type 1 and 
type 2. Type 1A DM results from autoimmune beta cell destruction, which leads to 
insulin deficiency. Individuals with type 1B DM lack immunologic markers 
indicative of an autoimmune destructive process of the beta cells. However, they 
develop insulin deficiency by unknown mechanisms and are ketosis prone. 
Relatively few patients with type 1 DM are in the type 1B idiopathic category. 
Type 2 DM is a heterogeneous group of disorders characterized by variable 
degrees of insulin resistance, impaired insulin secretion, and increased glucose 
production. Distinct genetic and metabolic defects in insulin action and/or 
secretion give rise to the common phenotype of hyperglycemia in type 2 DM 
(Harrison 2009).                                                                                                                       
 
1.1.2 Type 1 diabetes mellitus 
 
Type 1A DM develops as a result of the synergistic effects of genetic, 
environmental, and immunologic factors that ultimately destroy the pancreatic beta 
cells. Individuals with a genetic susceptibility have normal beta cell mass at birth 
but begin to lose beta cells secondary to autoimmune destruction that occurs over 
months to years. This autoimmune process is thought to be triggered by an 
infectious or environmental stimulus and to be sustained by a beta cell–specific 
molecule. In the majority of individuals, immunologic markers appear after the 
triggering event but before diabetes becomes clinically overt. Beta cell mass then 
begins to decline, and insulin secretion becomes progressively impaired, although 
normal glucose tolerance is maintained. The rate of decline in beta cell mass varies 
widely among individuals, with some patients progressing rapidly to clinical 
diabetes and others evolving more slowly. Features of diabetes do not become 
evident until a majority of beta cells are destroyed (80%) and the individual 
becomes completely insulin deficient (Harrison 2009). Genetic susceptibility to 
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type 1A DM involves multiple genes. The major susceptibility gene for type 1A 
DM is located in the HLA region on chromosome 6. Polymorphisms in the HLA 
complex account for 40 to 50% of the genetic risk of developing type 1A DM. 
Most individuals with type 1A DM have the HLA DR3 and/or DR4 haplotype. 
Refinements in genotyping of HLA loci have shown that the haplotypes 
DQA1*0301, DQB1*0302, DQA1*501, and DQB1*0201 are most strongly 
associated with type 1A DM. The risk of developing type 1A DM is increased 
tenfold in relatives of individuals with the disease. Nevertheless, most individuals 
with predisposing haplotypes do not develop diabetes. In addition, most 
individuals with type 1A DM do not have a first-degree relative with this disorder 
(Harrison 2009). 
 
1.1.3 Type 2 diabetes mellitus 
 
Type 2 DM is characterized by three pathophysiologic abnormalities: impaired 
insulin secretion, peripheral insulin resistance, and excessive hepatic glucose 
production. Obesity, particularly visceral or central (as evidenced by the hip-waist 
ratio), is very common in type 2 DM. In the early stages of the disorder, glucose 
tolerance remains normal, despite insulin resistance, because the pancreatic beta 
cells compensate by increasing insulin output. As insulin resistance and 
compensatory hyperinsulinemia progress, the pancreatic islets in certain 
individuals are unable to sustain the hyperinsulinemic state. Then develops 
impaired glucose tolerance, characterized by elevations in postprandial glucose. A 
further decline in insulin secretion and an increase in hepatic glucose production 
lead to overt diabetes with fasting hyperglycemia. Ultimately, beta cell failure may 
ensue (Harrison 2009). 
 
1.1.4 Metabolic abnormalities 
 
Insulin resistance: The decreased ability of insulin to act effectively on peripheral 
target tissues (especially muscle and liver) is a prominent feature of type 2 DM 
and results from a combination of genetic susceptibility and obesity. Insulin 
resistance is relative, however, since supernormal levels of circulating insulin will 
normalize the plasma glucose. Insulin dose-response curves exhibit a rightward 
shift, indicating reduced sensitivity, and a reduced maximal response, indicating 
an overall decrease in maximum glucose utilization (30 to 60% lower than normal 
individuals). Insulin resistance impairs glucose utilization by insulin-sensitive 
tissues and increases hepatic glucose output; both effects contribute to the 
hyperglycemia. Increased hepatic glucose output predominantly accounts for 
increased fasting plasma glucose levels, whereas decreased peripheral glucose 
usage results in postprandial hyperglycemia. The precise molecular mechanism of 
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insulin resistance in type 2 DM has not been elucidated. Insulin receptor levels and 
tyrosine kinase activity in skeletal muscle are reduced, but these alterations are 
most likely secondary to hyperinsulinemia and are not a primary defect. Therefore, 
post-receptor defects are believed to play the predominant role in insulin 
resistance. Another emerging theory proposes that elevated levels of free fatty 
acids, a common feature of obesity, may contribute to the pathogenesis of type 2 
DM. Free fatty acids can impair glucose utilization in skeletal muscle, promote 
glucose production by the liver, and impair beta cell function (Harrison 2009). 
Impaired insulin secretion: Insulin secretion and sensitivity are interrelated. In 
type 2 DM, insulin secretion initially increases in response to insulin resistance to 
maintain normal glucose tolerance. In the beginning, the insulin secretory defect is 
mild and selectively involves glucose-stimulated insulin secretion. The response to 
other nonglucose secretagogues, such as arginine, is preserved. Eventually, the 
insulin secretory defect progresses to a state of grossly inadequate insulin 
secretion. The reason(s) for the decline in insulin secretory capacity in type 2 DM 
is unclear. The metabolic environment of diabetes may also negatively impact islet 
function. For example, chronic hyperglycemia paradoxically impairs islet function 
(“glucose toxicity”) and leads to a worsening of hyperglycemia. In addition, 
elevation of free fatty acid levels (“lipotoxicity”) and dietary fat may also worsen 
islet function. 
Increased hepatic glucose production: In type 2 DM, insulin resistance in the liver 
rejects the failure of hyperinsulinemia to suppress gluconeogenesis, which results 
in fasting hyperglycemia and decreased glycogen storage by the liver in the 
postprandial state. Increased hepatic glucose production occurs early in the course 
of diabetes, though likely after the onset of insulin secretory abnormalities and 
insulin resistance in skeletal muscle. 
 
1.2 Genetic consideration 
 
Polymorphisms in IRS-1 may be associated with glucose intolerance, raising the 
possibility that polymorphisms in various postreceptor molecules may combine to 
create an insulin-resistant state. The pathogenesis of insulin resistance is currently 
focused on a PI-3-kinase signaling defect, which reduces translocation of GLUT4 
to the plasma membrane, among other abnormalities. Of note, not all insulin signal 
transduction pathways are resistant to the effects of insulin [e.g., those controlling 
cell growth and differentiation and using the mitogen-activated protein (MAP) 
kinase pathway]. A common aminoacid polimorfism of PPARγ (peroxisome 
proliferator-activated receptor-γ) has been associated to type 2 diabetes (Altshuler 
et al. 2000). Individuals omozygotes for Pro12 allele are more insulin resistant and 
present a risk of development of T2D 1,25 times higher than eterozygotes for allels 
Ala12/Pro12. Modifications of Calpain-10 gene have been also associated to T2D. 
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Affected people have an increase of 3 times in risk of development of T2DM. 
These modifications affect both beta cell function and insulin function on muscle 
and adipose tissue (Horikawa et al 2000). The Phosphoprotein Enriched in 
Diabetes/ Phosphoprotein Enriched in Astrocytes-15 (PED/PEA-15) is a 15 kDa 
cytosolic protein widely expressed in different tissues and highly conserved among 
mammals, whose gene maps on human chromosome 1q21-22 (Estellès et al. 
1996). Overexpression of the PED/PEA-15 gene is a common defect in type 2 
diabetes. During a study using a differential display technique to identify genes 
whose expression was altered in type 2 diabetes, it has been demonstrated that 
both PED/PEA-15 mRNA and protein levels were overexpressed in fibroblasts 
from type 2 diabetics compared with non-diabetic individuals. Also skeletal 
muscle and adipose tissues, two major sites of insulin resistance in type 2 diabetes, 
showed the same behaviour (Condorelli et al. 1998). Furthermore, a recent study 
showed that PED/PEA-15 overexpression represents a common abnormality in 
both T2 DM and their First Degree Relatives (FDR) (Velentino et al. 2006). Cells 
overexpressing PED/PEA-15 showed an impaired insulin-dependent glucose 
uptake. Transgenic mice overexpressing PED/PEA-15 exhibit mildly elevated 
random-fed blood glucose levels and become hyperglycemic after glucose loading, 
indicating that increased expression of this gene is sufficient to impair glucose 
tolerance. Moreover, transgenic mice become diabetic after administration of high-
fat diets, indicating that, in vivo, the overexpression of PED/PEA-15 in 
conjunction with environmental modifiers may lead to diabetes (Vigliotta et al. 
2004). Thus, these findings identify PED/PEA-15 as a novel gene controlling 
insulin action contributing, under appropriate environmental conditions, to genetic 
susceptibility to type 2 diabetes in humans.  
 
1.3 Hyperglicemia and diabetic complication 
 
Type 1 DM and type 2 DM share the phenotype of hyperglycemia. Prolonged 
hyperglycemia is responsible for the onset of diabetic complications. Four main 
hypotheses about how hyperglycaemia causes diabetic complications have been 
generated. The four hypotheses based on distinct biochemical abnormalities are: 
increased polyol pathway flux; increased advanced glycation end-product (AGE) 
formation; activation of protein kinase C (PKC) isoforms; and increased 
hexosamine pathway flux (for further details see: Brownlee 2001). In human 
diabetes, the resulting problems are grouped under "microvascular disease" (due to 
damage to small blood vessels) and "macrovascular disease" (due to damage to the 
arteries). The damage to small blood vessels leads to a microangiopathy, which 
can cause one or more of the following: retinopathy, neuropathy, or nephropathy. 
Macrovascular disease leads to cardiovascular disease, to which accelerated 
atherosclerosis is a contributor of coronary artery disease, leading to angina or 
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myocardial infarction, stroke, peripheral vascular disease, diabetic myonecrosis 
('muscle wasting') or diabetic foot (Harrison 2009). 
 
1.4 Diabetic foot 
 
Diabetic foot ulcers (DFUs), a leading cause of amputations, affect 15% of people 
with diabetes. A series of multiple mechanisms, including decreased cell and 
growth factor response, lead to diminished peripheral blood flow and decreased 
local angiogenesis, all of which can contribute to lack of healing in persons with 
DFUs. Most commonly, patients have neuropathy, which could be causative. 
When coupled with an impaired ability to fight infection, these patients become 
largely unable to mount an adequate inflammatory response. Thus, the DFU that 
may look like a healing wound becomes a portal for infection that can lead to 
sepsis and require limb amputation. Over 100 known physiologic factors 
contribute to wound healing deficiencies in individuals with diabetes. These 
include decreased or impaired growth factor production (Galkowska et al.2006), 
angiogenic response (Galiano et al. 2004), macrophage function (Maruyma et al. 
2007), collagen accumulation, epidermal barrier function, quantity of granulation 
tissue, keratinocyte and fibroblast migration and proliferation, number of 
epidermal nerves (Gibran et al. 2002), bone healing, and balance between the 
accumulation of ECM components and their remodeling by matrix metalloprotease 
(MMPs) (Lobman et al. 2002). Wound healing occurs as a cellular response to 
injury and involves activation of keratinocytes, fibroblasts, endothelial cells, 
macrophages, and platelets. Many growth factors and cytokines released by these 
cell types are needed to coordinate and maintain healing. 
 
1.4.1 Wound healing physiology 
 
Wound healing is often artificially compartmentalized into three phases. None of 
these phases correspond to a precisely defined period of time, and all phases 
overlap to a certain degree. They are the inflammatory phase, the proliferative 
phase, and the maturational phase (Falanga 2005). The inflammatory phase is 
characterized by hemostasis and inflammation. Wound healing begins with the 
formation of a fibrin plug consists of platelets embedded in a meshwork of mainly 
polymerised fibrinogen (fibrin), fibronectin, vitronectin, and thrombospondin; it is 
an immediate way to ward off bacteria and provide temporary wound coverage. 
Within the plug, platelets aggregate and release a wide range of growth factors, 
including platelet-derived growth factor (PDGF) and transforming growth factor 
(TGF) β1, fibroblasts growth factor (FGF-2), vascular endothelial growth factor 
(VEGF), hepatocyte growth factor (HGF), insulin growth factor (IGF), epidermal 
growth factor (EGF), and sphingosine-1-phosphate (S1P). Together, this growth 
factors influences many cells, including fibroblasts, keratinocytes, and endothelial 
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cells (Baum et al 2005).  The ingress of Polymorphonuclear cells (PMNs) to the 
injured aerea initiates the inflammatory phase. PMNs serve as early “cleaners” of 
the the wound by removing cellular debris, foreign particles, and bacteria 
(Lawrence 1998). They are a major source of several proinflammatory cytokines, 
such as IL-1α, IL-1β, IL-6, and tumor necrosis factor (TNF)- α (Werner et al 
2003). After PMNs at the wound site arrive macrophages that also remove debris, 
foreign particles, bacteria and secrete a number of growth factors and cytokines 
(Baum et al 2005). The inflammatory process is perpetuated through macrophage 
production of proinflammatory cytokines (Hubner et al 1996).               
The second stage of wound healing is the proliferative phase. Granulation tissue 
formation, migration, production of extracellular matrix (ECM), angiogenesis, and 
reepithelialization are the principal steps in this anabolic portion of wound healing. 
The components of the granulation tissue include fibroblasts, collagen (produced 
by fibroblasts) and blood vessels. Fibroblasts are the most important mesenchymal 
cells involved in wound healing (Lawrence 1998) given their dual roles of 
“factory”and “machinery.” As factories, fibroblasts produce the collagen-based 
ECM. As “machinery,” fibroblasts help reapproximate wound edges through their 
contractile properties. The processes of migration, proliferation, and ECM 
production are the key steps in the regeneration of a functional dermis. The 
increase in fibroblast population in the provisional ECM is due to the influx of 
migrating cells in addition to the proliferation of cells and is stimulated by PDGF, 
NGF, TGF-β, CTGF, and cysteine-rich 61 (Cyr61). Two of the “factory-like” roles 
of fibroblasts include the production of a permanent ECM (including collagen, 
glycosaminoglycan [GAG], and proteoglycans) and growth factors, which regulate 
the function of other cells in the matrix (Baum et al 2005).  
Angiogenesis is the process by which damaged blood vessels are replaced by 
“sprouts” from intact capillaries in the local vicinity of the wound. Several growth 
factors and cytokines, produced during the inflammatory phase of wound healing, 
stimulate and regulate angiogenesis. Endothelial cells migrate into the wound 
along the provisional ECM in a manner similar to that of fibroblasts (Senger et al. 
1996). Endothelial migration is stimulated by VEGF, FGF, angiopoietin, and TGF-
β (Baum et al 2005). The ECM influences angiogenesis. Together, the various 
components of the ECM, such as fibronectin, collagen, and vitronectin, provide 
structural support for the invading capillaries, in addition to serving as a repository 
of important growth factors, such as FGF-2 and TGF-β (Witt and Lander 1994)  
The gross morphologic changes that occur during reepithelialization include 
sloughing of any residual eschar and, ultimately, the reestablishment of intact 
epidermis over granulation tissue. As the process of reepithelialization progresses, 
a mass of keratinocytes moves across the granulation tissue. At the leading edge of 
the wedge are migrating keratinocytes, which leave a stratified layer of 
proliferating keratinocytes in their wake. This process, known as contact guidance, 
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continues until keratinocytes from opposing sides of the wound reestablish 
contact. Keratinocytes are stimulated to migrate, proliferate, and eventually 
differentiate by a number of factors. FGF-2, FGF-7, FGF-10, and TGF-
β demonstrate a positive influence on migration; HB-EGF, HGF, NGF, IL-6, GM-
CSF, nitric oxide, leptin, and secretory domain of β-amyloid precursor protein 
(sAPP) demonstrate a positive influence on cell proliferation (Baum et al 2005).   
The final phase of wound healing is the maturational phase. The clinical 
manifestations of wound maturation include contraction, decreased redness, 
thickness, induration, and increased strength. Fibroblasts and their products, 
collagen and MMPs, along with blood vessels, constitute the main participants in 
wound maturation. At this stage, the wounded skin regains its strength and 
elasticity, and proceeds through reorganization of the collagen and elastic fibers 
for final reconstruction of the dermis. The scar-tissue formation marks the 
termination of the healing process since all of the other assessed parameters have 
returned to prewounding levels and distribution (Braiman-Wiksman et al 2007). 
 
1.5 Molecular mechanism of wound healing 
 
Wound healing involves a complex interaction and equilibrium of cells, cytokines 
and growth factors working in concert. Two major cellular functions are necessary 
for a proper wound healing: cell proliferation and motility. 
 
1.5.1 Cell proliferation 
 
Fundamental part of the answer to the damage in the process of wound healing is 
the cellular proliferation. The mostly interested cells are fibroblasts and the 
endotelial cells. Cell proliferation is triggered by the binding of a messenger 
molecule to a specific receptor of the target cell. In mammalian cells the cascade 
often is begun from the activation of a receptor with intrinsic tyrosin-kinase 
activity by interaction with a growth factor, such as EGF, FGF, PDGF and IGF-1. 
The interaction with the ligand induces the dimerization of the receptor and the 
autophosphorylation on tyrosine residues. Phosphorylated tyrosines represent site 
of protein-protein interaction and act as activation site for intracellular proteins 
responsible for transduction of the signal from the cellular surface to the nucleus. 
In particular, there are three main pathways of signalling that have a primary role 
in the stimulation of the cellular proliferation. 
 
• RAS/MAPK pathway 
Receptor-linked tyrosine kinases such as the epidermal growth factor receptor 
(EGFR) are activated by extracellular ligands. Binding of EGF to the EGFR 
activates the tyrosine kinase activity of the cytoplasmic domain of the receptor. 
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The EGFR becomes phosphorylated on tyrosines. Docking proteins such as GRB2 
contain SH2 domains that bind to the phosphotyrosines of the activated receptor 
(Shulze et al. 2005). GRB2 binds to the guanine nucleotide exchange factor SOS 
by way of an SH3 domain of GRB2. When the GRB2-SOS complex docks to 
phosphorylated EGFR, SOS becomes activated (Zarich et al. 2006). Activated 
SOS promotes the removal of GDP from Ras. Ras can then bind GTP and become 
active. Activated Ras activates the protein kinase activity of RAF kinase (Avruch 
2001), a serine/threonine-selective protein kinase. RAF kinase phosphorylates and 
activates MEK, another serine/threonine kinase. MEK phosphorylates and 
activates Extracellular Signal-regulated kinase 1e 2 (Erk 1/2). Active Erk 1/2 
translocates into the nucleus and phosphorylates several transcription factors 
stimulating cell proliferation (Figure 1).  
 
                       
Figure 1. Erk 1/2 and Akt/PKB pathway in cell proliferation. 
 
• PKCS’ pathway 
PKCs proteins belong to a multigenic family including at least 14 isoforms with 
different catalytic and regulatory proprieties (Schmeichel et al 2003). PKCs can be 
dived in three subgroups on the basis of their structural features and cofactor 
dependency. Classical PKCs (α, βI , βII and γ) are Ca2+ and diacylglycerol (DAG) 
dependent; novel PKCs (δ,ε, η, e  θ) are DAG dependent but are Ca2+ 
independent; le atypical PKCs (ζ, λ e ι) are both Ca2+ and DAG independent. 
PKCs play an important role in several cellular functions such as proliferation, 
metabolism, vescicular traffic and cytoskeleton organization. In response to 
growth factors one of the mechanisms of PKCs activation is mediated by 
phospholypase C e D production of DAG. 
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• PI3K/PKB pathway 
PI3K family includes several isoforms divided in three classes based on structural 
features and regulation mechanisms (Schlessinger 1993). The most known class is 
the Ia that is activated in response to growth factors. Class Ia consisting of 
heterodimers composed of a 85 kDa regulatory subunit (p85) and of a 110 kDa 
lipidic kinase catalytic subunit (p110). Interaction of p85 with phosphorylated 
tyrosines on activated growth factors receptors or on adapting proteins induces a 
conformational change that modulates p110 catalytic activity (Goalstone 1998). 
Activated PI3K phosphorylates the membrane lipid phosphatidylinositol on 3’ 
position of inositolic ring inducine an increase of phosphatidylinositol 3-phosphate 
(PI3P), of phosphatidylinositol 3, 4-biphosphate (PI3,4P2) and of 
phosphatidylinositol 3,4,5 tri-phosphate (PI3,4,5P3). Phosphorylate 
phosphatidylinositol act as second messenger and mediate PI3K effect on 
cytoskeleton, cell cycle, vescicular traffic, glucose metabolism and cell survival. 
Phospholipid activated proteins include some Ca+2-indipendent PKC isoforms, 
such as PKCδ and PKCζ (Blumberg et al 1996), p70S6 kinase, small GTPase Rho 
e Rac and serine-threonine-kinase PKB/Akt (Jaken 1996) p70S6 kinase 
phosphorilates 40S ribosomial subunit protein S6, inducing G1-S cell cycle 
transition; small GTPase Rho e Rac regulate actin cytoskeleton; PKB/Akt 
phosphorylates and sequestrate into cytosol proapoptotic protein Bad. Thus Bad is 
unable to associate to 1 6 Bcl-2 and to translocate into mitochondria to induce 
cytocrome C release and to trigger apoptotic signal (Cantrell 2001) (Figure 2).  
 
1.5.2 Cell migration 
 
Cell migration at wound site is another fundamental event in wound healing 
process. The crawling movements of animal cells are among the most difficult to 
explain at the molecular level. Different parts of the cell change at the same time, 
and there is not a single, easily identifiable locomotory organelle (analogous to a 
flagellum, for example). Although actin forms the basis of animal cell migration, it 
undergoes many different transformations as the cell moves forward, assembling 
into lamellipodia and microspikes, associating with focal contacts, forming stress 
fibers, and so on. In broad terms, three distinct processes can be identified in the 
crawling movements of animal cells: protrusion, in which lamellipodia and 
microspikes (or filopodia) are extended from the front of the cell; attachment, 
where the actin cytoskeleton makes a connection with the substratum; and traction, 
where the body of the cell moves forward. Protrusion is a function of the leading 
edge of the cell. Actin-rich lamellipodia and microspikes (or filopodia) extend 
forward over the substratum, a process that is accompanied by actin 
polymerization. It seems likely that the protrusion is driven by actin 
polymerization at the leading edge, although this is still debated. Myosin-I motors 
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attached to the plasma membrane could also drive the cell forward by actively 
walking along actin filaments. Rapidly motile cells, such white blood cells, make 
more diffuse contacts with the substratum. It is thought, however, that similar 
principles apply to focal contacts of fibroblasts: transmembrane receptors for 
extracellular matrix proteins link the plasma membrane to the substratum, and 
actin filaments in the cytoplasm interact with the cytoplasmic domains of these 
receptors through actin-binding proteins. The details of these important 
interactions are uncertain, but it is clear that the cell contacts with the substratum 
must be continually made and broken as the cell moves forward. The dynamic 
assembly and disassembly of focal adhesions plays a central role in cell migration. 
During cell migration, both the composition and the morphology of the focal 
adhesion changes. Initially, small (0.25μm²) focal adhesions called "focal 
complexes" are formed at the leading edge of the cell in lamellipodia: they consist 
of integrin, and some of the adapter proteins, such as talin and paxilin. Many of 
these focal complexes fail to mature and are disassembled as the lamellipodia 
withdraws. However, some focal complexes mature into larger and stable focal 
adhesions, and recruit many more proteins such as zyxin. Once in place, a focal 
adhesion remains stationary with respect to the ECM, and the cell uses this as an 
anchor on which it can push or pull itself over the ECM. As the cell progresses 
along its chosen path, a given focal adhesion moves closer and closer to the 
trailing edge of the cell. At the trailing edge of the cell the focal adhesion must be 
dissolved. The mechanism of this is poorly understood and is probably instigated 
by a variety of different methods depending of the circumstances of the cell. 
Traction is perhaps the most mysterious part of cell locomotion. In many cases it is 
thought that the force for cell locomotion is generated near the front of the cell and 
that the nucleus and bulk cytoplasm are dragged forward passively. The force 
generation can be viewed in different ways. The leading part of the cell might 
actively contract like a muscle fiber and thus pull on the back of the cell. In 
another view polymerization of actin filaments at the front of the cell extends the 
actin cortex forward, and the rear of the cell is then carried forward by the 
contractile force of the resulting cortical tension (Figure 2) (Alberts).  
Also cell motility is triggered by binding of signal molecules to specific receptors 
on cell surface. Ligand-receptor interaction activates several pathway of 
transduction inside the cell inducing rearrangement in cytoskeletron in order to 
promote migration. Mitogen activated protein kinase (MAPK) pathway is one of 
the most important signalling system in cell migration. In particular, JNK (Jun N-
terminus kinase), p38 and ERKs play a pivotal role (Huang et al 2004).  
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Figure 2. Cell movement model 
 
• JNK signaling 
JNK is activated in response to various extracellular stimuli, including TNF, EGF, 
PDGF, TGF-ß and lysophosphatidic acid, as well as diverse environmental stresses 
(Huang et al 2004). These activate MAPKKKs: such as MEKK1 and MLK, which 
phosphorylate and activate two MAPKKs, MKK4 and MKK7. In turn, these 
phosphorylate the threonine and tyrosine residues within the Thr-Pro-Tyr motif in 
the JNK activation loop. Accumulating evidence implicates the JNK pathway in 
regulation of cell migration. First, activation of JNK correlates with an increase in 
cell migration in several cell types. Second, the signaling molecules that activate 
JNK are essential for cell migration. MEK kinase 1, an upstream kinase in the JNK 
pathway, is essential for cell migration and the developmental process of eyelid 
closure. Third, inhibition of JNK by either the chemical inhibitor SP600125 or the 
dominantnegative mutant JNK1AF, significantly impairs the rate of migration of 
several different cell types. Fourth, using a gene knockout approach has been 
demonstrated that JNK activity plays a crucial role in the migration of fibroblasts 
in wound healing assays. Active JNK is found in cytoplasmic locations providing 
evidence for cytoplasmic functions of JNK, in addition to its established nuclear 
functions. Along with the various well-known transcription factors and apoptosis-
related proteins, several cytoskeleton-associated proteins and signaling molecules 
as well as adaptor proteins have recently been identified as JNK substrates. These 
include the intermediate filament protein keratin 8, microtubule-associated 
proteins (MAPs), such as MAP1B, MAP2, DCX and SCG10, the actin-binding 
protein spir, the protein kinase p90RSK, and the adaptors insulin receptor substrate 
1 (Irs-1), p66ShcA and paxillin. Of these, paxillin, spir, DCX, MAP1B and MAP2 
are probably directly involved in cell migration. These findings collectively 
implicate JNK in the control of cell migration in a broad range of cell types and in 
several developmental processes (Huang et al 2004). 
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• p38 signaling 
The activity of p38 is stimulated by many growth factors, cytokines, and 
chemotactic substances, such as VEGF, FGF, PDGF, TNF, interleukins, 
lipopolysaccharide (LPS) and formyl-methionylleucyl- phenylalanine (fMLP). The 
upstream MAPK cascade in this case includes MAPKKKs such as MLK3, DLK 
and TAK1, which phosphorylate and activate MKK3 and MKK6, which in turn 
phosphorylate and activate p38. It is well known that p38 is involved in 
inflammation, apoptosis, cardiomyocyte hypertrophy and cell differentiation. 
Recently, several studies have suggested it is also involved in the migration of 
diverse cell types. SB203580 and SB202190, inhibitors of p38, inhibit the 
migration of smooth muscle cells induced by PDGF, TGFß and IL-1ß, porcine 
aortic endothelial cells challenged with PDGF and VEGF, neutrophils stimulated 
with fMLP, mast cells treated with stem cell factors and antigen, corneal epithelial 
cells stimulated with hepatocyte growth factor, mouse embryonic fibroblasts 
challenged with PDGF and IL-1, NMuMG and MDA-MB-231 mammary 
epithelial cells treated with EGF and TGFß1 and NLT neuronal cells stimulated 
with Gas6 (encoded by growth arrestspecific gene 6). Moreover, p38AF, a 
dominant negative mutant of p38, also inhibits the migration of smooth muscle 
cells induced by PDGF, TGFß and IL-1ß, NMuMG and MDA-MB-231 mammary 
epithelial cells in response to EGF and TGFß1 and NLT neuronal cells stimulated 
with Gas6. Taken together, these findings demonstrate that p38 is involved in 
growth-factor- and cytokine-induced cell migration (Huang et al 2004). 
 
• ERK/MAPK signaling 
The Erk MAPKs are the most extensively studied subfamily of MAPKs. Erk has 
been implicated in the migration of numerous cell types. The Erk pathway 
inhibitors PD98059 and U0126 inhibit the migration of diverse cell types in 
response to cell matrix proteins, such as fibronectin, vitronectin and collagen, 
growth factors such as VEGF, FGF, EGF, insulin and other stimuli, such as fetal 
calf serum and urokinase plasminogen activator (uPA). Moreover, a dominant 
negative Erk mutant or inhibition of Erk by an antisense strategy also inhibits cell 
migration. Erk is thus an important factor in the regulation of cell migration. Erk 
phosphorylates serine or threonine residues followed by proline. The most 
stringent consensus sequence is Pro-Leu-Ser/Thr-Pro. Identified substrates include 
several protein kinases, such as p90rsk, MSK1, MNK1/2, myosin light chain 
kinase (MCLK) and FAK, the protease calpain, paxillin, as well as transcription 
factors and nuclear proteins. Of these MLCK, calpain, and FAK are most likely to 
be involved in Erk-mediated cell migration. Erk regulates FAK-paxillin complex 
sophistically: initially it promotes complex-assembly by phosphorylation of 
paxillin and then promote disassembly by subsequent phosphorylation of FAK. It 
is possible that Erk-modulated disassembly of the FAK-paxillin complex is 
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involved in focal adhesion disassembly, but its precise role and the mechanism 
remain to be completely clarified. Erk also participates in cell migration by 
suppressing the ability of integrins to bind to their extracellular matrix ligands. It is 
well known that the Ras-Raf- MEK-Erk pathway regulates integrin activation (the 
affinity of an integrin for its substrate), although the molecular mechanism remains 
to be elucidated. Because dynamic integrin activation is required for cell 
migration, Erk might also play an important role regulating cell migration, by 
regulating integrin activation (Figure 3) (Huang et al 2004). 
 
                                   
Figure 3. Erk 1/2 pathway in cell migration. 
 
1.6 Wound healing in diabetes 
 
Diabetic individuals exhibit a documented impairment in the healing of acute 
wounds, which often develop in chronic non-healing diabetic foot ulcers (DFUs). 
The impaired healing of both DFUs and acute cutaneous wounds in persons with 
diabetes involves multiple complex pathophysiological mechanisms. Diabetic 
ulcers are often stalled in the inflammatory phase with impaired granulation tissue 
formation and are always accompanied by hypoxia. A situation of prolonged 
hypoxia is detrimental for wound healing. Indeed, intact and functional 
microcirculation is necessary for an adeguate nutrition of tissues, for discarting 
metabolism’s products and for an effective inflammatory response. Hypoxia can 
amplify the early inflammatory response, thereby prolonging injury by increasing 
the levels of oxygen radicals. Hyperglycemia can also add to the oxidative stress 
when the production of ROS exceeds the anti-oxidant capacity. Several studies 
have documented an association of the overproduction of these oxygen free 
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radicals and its deleterious effects on wound healing by perpetuating 
inflammation, and promoting premature apoptosis of matrix producing cells (Woo 
et al. 2007). Moreover wound healing is thwarted in the inflammatory stage 
because ECM is degraded more rapidly than it is synthesized. High levels of 
metalloproteases are a feature of diabetic foot ulcers, and the MMP levels in 
chronic wound fluid are almost 60 times higher than those in acute wounds. This 
increased protease activity supports tissue destruction and inhibits normal repair 
processes (Sibbald et al. 2008). Increased bacterial burden also plays an important 
role in the chronicity of ulcers. Impaired host defense occurs at the cellular level 
where leukocyte function and intracellular killing are both affected, rendering this 
patient population more susceptible to superficial increased bacterial burden and 
deep infection (Calhoun et al. 2002; Sibbald et al. 2006). Finally, the diabetic 
fibroblast response to mitogenic stimulation is often suboptimal with the 
production of low levels of various growth factors and collagen. Accumulating 
data demonstrates that persons with diabetes have impaired cell migration and 
insufficient angiogenesis to support the collagen synthesis necessary for mature 
granulation and subsequent reepithelialisation (Falanga et al. 2005).  
 
1.6.1 The inflammatory component of diabetic wound healing 
 
The inflammatory response is required for optimal wound healing. 
Polymorphonuclear neutrophils (PMN) preside at the first wave of immune cells 
that invade the wound bed and they contribute to the production of inflammatory 
cytokines (Borst 2004). In contrast to the physiological process, in case of diabetes 
the inflammatory reaction PMN infiltration is intense and prolonged, sustaining 
the generation of pro-inflammatory cytokines and a deregulated production of 
tissue matrix metalloproteinases (MMPs), which sharply limit the process of 
granulation tissue formation and maturation. Although it is generally accepted that 
the chronic diabetic ulcer is stalled in the inflammatory phase of the normal 
healing process, this inflammatory reaction does not necessarily imply a 
physiological bacterial local control. On the contrary, diabetic individuals are more 
susceptible to both wound infection and hyperinflammation, which is not 
pathogenically detachable from the elevated levels of tumour necrosis factor-alpha 
(TNF-α) and interleukin (IL)-6 (Borst 2004). The search for explanations on this 
exaggerated inflammatory reaction has identified critical elements aiming at both 
soluble and cellular factors. Data derived from diabetic rodent models have 
documented a prolonged expression of macrophage inflammatory protein-2 (MCP-
2) and macrophage chemoattractant protein-1 (MCP-1) (O’Brien et al. 2006). 
Their dysregulation and sustained expression appears to be directly associated with 
the increased and protracted infiltration of both PMN and macrophages into the 
diabetic wound (Wetzler et al 2000). Furthermore the granulocytes secrete pro-
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inflammatory cytokines, particularly TNF-α and IL-1b, capable of directly 
stimulating the synthesis of MMPs, all with a remarkable cytotoxic and 
prodegradative potential (Schonfelder et al 2005). The observation that diabetic 
wounds are enriched in MMPs provides support for the premise that impaired 
growth factor availability may act as a healing and limiting factor (Wetzler et al. 
2000). In addition to MMPs, high levels of TNF-α in the wound have been 
identified as a molecular predictive factor for closure failure (Acosta et al 2008). 
Type 2 diabetes is associated with high serum levels of inflammatory cytokines 
such as TNF-α (Mishima et al 2001). Within the wound, TNF-α stimulates its own 
secretion and that of IL-1b that contributes to a persistent inflammatory status. 
TNF-α deregulation is also associated to connective tissue destruction, thus 
pushing towards a catabolic slope (Liu et al. 2006). Genetic ablation of TNF-α 
receptor-1 improves the general wound healing profile by enhancing angiogenesis, 
collagen production and reepithelialisation, significantly reducing neutrophil and 
macrophage infiltration; decreasing gene expression as well as protein levels of 
IL-1α, IL-1β, MCP-1, macrophage inflammatory protein-1 alpha (MIP1-α), and 
macrophage inflammatory protein-2 (MIP-2); and increased gene expression and 
protein levels of TGF-β1, connective tissue growth factor (CTGF), and VEGF 
(Goren et al. 2006). This indicates that TNF-α inhibition is apparently sufficient to 
neutralise the misbehaving inflammatory machinery in non healing wounds, so as 
to assist in reprogramming the whole local microenvironment. The effects 
associated with this intervention include both the restitution of the epithelial 
sector, as the restoration of granulation tissue outgrowth in terms of cellularity 
(viability of endothelial cells and fibroblasts), and extracellular matrix synthesis 
(Liu et al. 2006). Summarising, TNF-α is a major driving force towards the onset 
and perpetuation of the wound pro-inflammatory and pro-catabolic phenotype. As 
a concomitant side effect, TNF-α intoxicates fibroblasts and vascular precursor 
cells. Fibroblasts proliferation and migration are arrested, matrix ingredients 
secretion is impaired and at the end, these fibroblasts are bound to suicide (Figure 
4). Analternative pathogenic cascade establishes a connection between TNF-α 
levels and tissues insulin resistance from where the skin is not excluded. Systemic 
TNF-α levels are linked to an impaired healing response under diabetic and obese 
conditions in ob/ob mice. Chronic exposure of keratinocytes to TNF-α inhibits 
insulin-stimulated glucose uptake. Indeed TNF-α neutralisation is able to restore 
insulin sensitivity by reestablishing the expression and functionality of the 
hormone’s receptor (Goren et al. 2006). 
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Figure 4. The cytotoxic effect of pro-inflammatory cytokines and glycation products in diabetic 
wound failure.  
 
1.6.2 Fibroblasts dysfunction in diabetes 
 
Fibroblasts play a key role in wound healing process. Infact, they produce, secrete 
and remodel ECM and act as signal cells. It is clear that any impairment of 
fibroblasts’ function induces an impairment in wound healing. In diabetes, in 
particular, has been demonstrated an impairment in proliferation, migration and 
ECM synthesis. In detail, diabetic fibroblasts produce and secrete large amount of 
matrix metalloprotease (MMPs). Physiologically MMPs promote cell migration 
and healing, nevertheless increased concentration observed in diabetes act as 
negative regulator of both process. Moreover VEGF production is reduced in 
diabetic fibroblasts. VEGF is fundamental for vascular development during tissue 
repair; decreased VEGF levels are responsible for a reduced angiogenetic response 
that impairs the following proliferation and ECM deposition phases of wound 
healing. (Lerman et al. 2003). 
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2. AIM OF THE STUDY 
 
 
Diabetes’ incidence is growing up making it one of the most common health 
problems in western countries. Chronic complications, in particular, cause a 
significant decrease in life span and life quality of diabetic patients and have a 
huge cost to public health worldwide. It was calculated that, in 2010, the US spent 
an estimated $22.9 billion on direct medical costs related to diabetes 
complications. A serious complication of diabetes is impaired healing, which can 
lead to diminished physical activity and in some cases to chronic wounds and limb 
amputation, having a big impact on life quality and life span of affected patients. 
Multiple factors contribute to deficient healing in a subset of diabetic patients 
(Braima-Wiksman 2007, Trousdale et al. 2009). They include altered host 
response, diminished anti-bacterial defences, prolonged inflammation, altered 
protease activity, tendency for vascular abnormalities, generation of an inadequate 
number of cells to accomplish rapid and robust healing, decreased growth factor 
production, failure to form a sufficient amount of extracellular matrix, and 
alterations in apoptosis that may interfere with healing by decreasing the number 
of cells that participate in new tissue formation (Galkowska et al. 2006; Shultz et 
al. 2009; Wall et al. 2008; Velander et al. 2008). In particular, fibroblasts play a 
pivotal role in tissue repair. They function both as synthesizer cells, depositing 
collagen-rich matrix, and as signalling cells, secreting growth factors important for 
cell-cell communication during the repair process (Giacco et al 2006). Any 
impediment to fibroblast functions prevents normal wound closure and results in 
chronic non-healing wounds. Noteworthy, alterations of fibroblast functions have 
been reported in individuals with type 2 diabetes (Lerman et al. 2003). 
Possibly genetic factors may contribute to wound healing dysregulation in a subset 
of diabetic patients. PED/PEA-15 is a gene over-expressed in several tissues and 
cell types including fibroblasts, of a large cohort of patients with type 2 diabetes 
(Condorelli et al. 1998; Valentino et al. 2006; Condorelli et al. 2001). PED/PEA-
15 gene product is a ubiquitously expressed protein, which has been implicated in 
the control of cell survival and growth and glucose metabolism (Fiory et al. 2009). 
Moreover its over-expression may lead to impaired glucose tolerance in transgenic 
mice (TgPED). Aim of this work has been to clarify in further detail the sequence 
of events that characterize the wound healing process in TgPED mice to establish 
if alteration if this gene may be a predictor factor to development of skin chronic 
complication in patients affected by diabetes.    
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3. MATERIALS AND METHODS 
 
3.1 Materials 
 
Tribromoethanol (Avertin®) was from Sigma-Aldrich (St. Louis, Mo). Media, sera, 
and antibiotics for cell culture were purchased from Invitrogen Ltd. (Paisley, 
United Kingdom). Rabbit polyclonal ERK1/2 and RhoA mouse monoclonal 
antibodies were from Santa Cruz Biotechnology (Santa Cruz, Calif.), and 
antibodies toward the phosphorylated forms of ERK1/2 were from Cell Signal 
Technology (Beverly, Mass). Rabbit polyclonal Paxillin antibodies were from 
Zymed Laboratories (Invitrogen Corporation, Calif.). Rabbit polyclonal 
fibronectin antibodies were from Chemicon (Millipore Corporation). Rabbit 
polyclonal H3-histone and β subunit of the Insulin-like growth factor-1 receptor 
antibodies were from Upstate (Millipore Corporation). Western blotting, ECL 
reagents were from Amersham (Arlington Heights, Ill.). Electrophoresis reagents 
were from BioRad. Rabbit polyclonal β-actin antibodies, Bisindolylmaleimide 
(BDM), PD98059 and mytomicin C were from Sigma-Aldrich (St. Louis, Mo.) 
 
3.2 In vivo wound healing and histological analysis 
 
We used 16 eight month old, sex and age matched, TgPED and Wt littermates 
mice for each time point of the study. The animals were anesthetized with a single 
intraperitoneal injection of tribromoethanol. The hair on the back of each mouse 
was cut and 2 full-thickness wounds (width about 4 mm, length about 2 cm) were 
made with scalpel (Braiman-Wiksman 2007). Wounds from all animals were 
harvested at 3, 4 and 6 days after injury. Samples were fixed in 10% neutral 
buffered formalin and subsequently processed, blocked and sectioned 
perpendicularly to the wound surface in 5μm consecutive sections. Healing of skin 
wounds was evaluated on haematoxylin-eosin (H&E) slides by measuring the 
distance between migration tongues using the measurement tool included in the 
digital microscope software. Granulation tissue–staining of proliferating cells with 
antibodies anti-proliferating cell nuclear antigen (PCNA), collagen fibres with 
Masson-Trichrom and H&E staining were used to assess the granulation-tissue 
formation. Granulation tissue was considered fully formed (100%) when the 
following parameters existed at wound gap: 1) a continuous layer of granulation 
tissue formed across the entire wound gap; 2) the layer of granulation tissue filled 
the entire wound depth (Braiman-Wiksman 2007). The inflammatory infiltrate was 
estimated by immunohistochemical-based quantification of neutrophils, 
macrophages and T-lymphocytes with anti-neutrophil antibody, anti-CD68 
antibody and anti-CD3 antibody, respectively (Hattori et al 2009).  PicroSirius 
Red/Fast Green was used for differential staining of collagen during matrix 
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production phase. FGF-2 was used for immunohistochemical-based quantification 
of fibroblast content.  All stained samples were examined under digital and light 
microscope by at least two trained pathologists in blind. The content of activated 
fibroblasts, infiltrated cells and collagen fibres was scored using a semi-
quantitative three point scale of range values. For activated fibroblasts and cellular 
infiltration, we attributed score 0 for no increase, score 1, 2 or 3 for little, moderate 
or high increase of cells content compared to adjacent tissue, respectively. For the 
extracellular matrix production we attributed score 0 for absence of collagen 
production, score 1 and 2 for 10-40% and 40-80% collagen fibres content 
compared to adjacent normal tissue respectively, and finally score 3 for wound 
matrix indistinguishable from adjacent normal tissue. All experiments were 
performed according to the guidelines and approved by the local Ethic Committee. 
 
3.3 Multiplex analysis 
 
To examine the expression of cytokines during dermal wound healing blood 
samples of Wt and TgPED mice subjected to skin injury were collected and 
analyzed. A Bio-Plex conventional assay kit for 27 cytokines was run following 
the manufacturer’s instructions (Bio-Rad Laboratories). Using the Bio- Plex 
Suspension Array System (Bio-Rad Laboratories) all samples were analyzed in 
duplicate. The methods were described in detail in the references Takamiya et al. 
2008. Furthermore, differences of cytokines expression between blood samples of 
Wt control and TgPED mice were statistically analyzed using the Student’s t-test, 
and P values of 0.05 or less were considered statistically significant. 
 
3.4 Directed in vivo angiogenesis assay (DIVAA) 
 
Sterile, surgical silicone tubing (0.15-cm internal diameter), these are referred to as 
“angioreactors”, were filled at 4°C with 18µl of Matrigel with or without 
angiogenic factors (500 ng/ml of either FGF-2 and VEGF). These were incubated 
at 37°C for 1 h to allow gel formation and and were implanted into the dorsal flank 
of 16 Wt and 16 TgPED mice. At 9 days after implantation, mice received a 100µl 
injection of 25 mg/ml of FITCdextran in phosphate-buffered saline (PBS) via tail 
vein. Angioreactors were then recovered at 30 min after intravenous injection. 
Quantification was performed by removal of the Matrigel and digestion in 200µl 
of Dispase solution for 1 hour at 37°C. After digestion, the incubation mix was 
cleared by centrifugation (5 min at 15,000xg) at room temperature and 
fluorescence of the supernatant aliquots were measured in 96-well plates using an 
HP model spectrofluorimeter (excitation 485 nm, emission 510 nm). The mean 
relative fluorescence ± SD for five replicate assays were determined by statistical 
analysis (Student’s t-test) (Guedez et al 2003). 
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3. 5 Isolation of mouse aortic endothelial cells 
 
Murine aortic endothelial cells were isolated from cells growing out of tissue 
explants. TgPED and Wt female mice, 10 week of age, were exsanguinated. The 
heart and lungs were aseptically removed from the chest cavity and placed in a 
petri dish containing Hank’s balanced salt solution. The aorta was removed from 
the heart. Connective tissue surrounding the exterior of the vessel was teased 
away, and the vessel was then washed briefly in HBSS. The aorta was then cut 
into four or five small segments (1.0-1.5 mm thick). The resulting tissue rings 
were then placed on edge into a 0.2% gelatin-coated 34-mm tissue culture well and 
allowed to anchor to the bottom of the well for 2-3 min. The explants were 
incubated at 37°C after the careful addition of 2 ml of DMEM 20% FBS 
supplemented with endothelial cells growth supplement (ECGS; Sigma-Aldrich). 
After sufficient outgrowth of non-fibroblast-like cells, the tissue fragments were 
removed. The remaining adherent cells were allowed to continue growing. 
Endothelial cells were identified by di-ID-acylated low-density lipoprotein (di-I-
LDL) (Biomedical Technologies Inc., Stoughton, MA) labeling. Isolated 
endothelial cells were grown at 37°C with DMEM 20% FBS supplemented with 
ECGS and used between 3 and 8 passages (Lincoln et al. 2003). 
 
3.6 Capillary-like tube formation on matrigel 
 
The EC were made quiescent by contact inhibition and an overnight starvation. 
After trypsinized, cells were then seeded on Matrigel. Briefly, 100 μl per well of 
this matrix solution was added to a 24-well culture plate. After gelation at 37 °C 
for 30 min, EC resuspended in DMEM 20% FBS supplemented with ECGS were 
plated on the top of the Matrigel at a density of 5×103 cells/well and incubated for 
8 days at 37 °C. Tube formation was observed using an light microscope. Images 
were captured and the number of the structure were quantified by counting all 
branches in three random fields from each well. Each experiment was repeated 
three times (Wang et al. 2009).   
 
3.7 Isolation and culture of fibroblasts, Western Blot, Cell fractionation 
 
TgPED, ped/pea-15 null (KO) and Wt control mice have been generated and 
characterized as described previously (Kitsberg et al 1999). Skin fibroblasts were 
obtained by punch biopsy from the animals. Cultures were established and grown 
as previously described (Atala and Lanza 2001), and used for experimental 
procedures between 3 and 10 passages. For Western blotting, the cells were 
solubilized in lysis buffer (50mM HEPES pH 7.5, 150mM NaCl, 4mM EDTA, 
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10mM Na4PO7, 2mM Na3VO4, 100mM NaF, 10% glycerol, 1% Triton X-100, 
1mM phenylmethylsulfonyl fluoride, 100 µg of aprotinin/ml, 1mM leupeptin) for 
60 min at 4°C. Lysates were clarified at 5,000 x g for 15 min. Solubilized proteins 
were then separated by SDS-PAGE and transferred onto 0.45-µm-pore-size 
Immobilon-P membranes (Millipore, Bedford, Mass.). Upon incubation with the 
primary and secondary antibodies, immunoreactive bands were detected by ECL 
according to the manufacturer's instructions. For cell fractions, the cells were 
solubilized in ice-cold fractionation buffer (20mM HEPES-NaOH, pH 7.4, 250mM 
sucrose, 25mM sodium fluoride, 1mM sodium pyrophosphate, 0.1mM sodium 
orthovanadate, 2µM microcystin LR, 1mM benzamidine) by passing them 10 times 
through a 22-gauge needle. Lysates were centrifuged at 800 x g for 5 min at 4°C. 
The nucleus pellet was solubilized in Buffer B (400mM NaCl, 2mM Na3VO4, 
1mM EGTA, 1mM DTT) while supernatants were further centrifuged at 100,000 x 
g for 20 min at 4°C. The final supernatants represents the cytosolic fraction. The 
membrane pellet was solubilized in Buffer. A containing 1% Triton X-100 and 
further centrifuged at 12,000 x g for 10 min at 4°C.  
 
3.8 Measurement of Rho activity  
 
Cellular Rho activity was measured by pull down assay using the Rho binding 
domain of Rhotekin fused to GST (GST-RBD). For determining Rho activity cells 
were extracted in Tris buffer (1% Triton X-100, 150 mM NaCl, 10 mM MgCl2, 10 
mg/ml leupeptin, 10 mg/ml aprotinin, 1 mM PMSF). Rho activity (percentage of 
GTP-bound Rho) is determined as the amount of RBD-bound Rho versus the total 
Rho in the lysate (Vial et al. 2003). 
 
3.9 Scratch wound healing assay  
 
Endothelial cells and fibroblasts were seeded at a density of 8×105 cells per well 
into the uncoated 6-well microplates, wounded by manually scratching with a 
pipette tip, washed twice with phosphate-buffered saline (PBS) and incubated at 
37°C, with or without mitomycin C (10 μg/ml), PD98059 (30 μM) or BDM (5 
μM), as indicated in individual experiments. Wound gap was photographed at 0 
and 24 h at the same location. Images of areas were collected with a camera 
coupled to the microscope and percentage of closure was calculated with NIH 
IMAGE J. These experiments were repeated at least three times.  
 
3.10 Time-Lapse Microscopy  
 
 Time-lapse microscopy (TLM) experiments were performed by using a video 
optical microscopy workstation which has been already described elsewhere 
 25  
(Dickinson and Tranquillo 1993). The images are captured by a cooled 
monochromatic CCD video camera. The samples were imaged every 10 min with 
a long working distance 10x objective in phase contrast for overall 24 h. The 
scratch assay were carried out in the TLM experiments and cell motion was 
analyzed offline as described in the following. 
 
3.11 Cell Tracking 
 
Image analysis of the scratch assay was performed by using a semi-automated Cell 
Tracking software. For each time step, about 40 cells on the wound edges were 
individually followed by manual overlaying each cell contour, and the coordinates 
of the contour points and of the cell centre of mass are stored on hard disk. To 
assist the operator in cell identification, the color-coded contour of each cell at the 
previous time step is also shown in the image overlay. From the centre of mass 
coordinates the trajectory of each cell was reconstructed for the whole experiment. 
Furthermore, average motility parameters of the cell population, such as velocity, 
were calculated as a function of time. The analysis of cell motility was based on 
the persistent random walk theory (Dickinson et al 1994; Matthes et al 1998), 
where it is assumed that cell motion is characterized by a diffusion coefficient 
(also referred to as the random motility coefficient) D (µm2/min) and a persistent 
time P (min). According to the theory, the mean square displacements are given by 
the equation   
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where <d2(t)> (µm2) is the mean square displacement of the tracked cell sample at 
time t. The trend predicted by Eq. 1 is linear at t >>P (i.e., <d2(t)>≈4Dt), with a 
slope proportional to the diffusion coefficient. The mean square displacements are 
calculated from the following relation  
 
( ) ( )[ ]∑ ∑
=
−
=
−++−+>=<
N
i
kM
j
iiii jykjyjxkjxkd
1 1
222 )()()()()(
  (2)  
 
where k is the current time expressed in units of the time interval µt between two 
consecutive image acquisitions, the double summation is on the index i 
representing cell number (up to the total cell number N) and on index j 
representing the number of intervals (the total number being M-k), x and y are the 
centre of mass coordinates obtained by cell tracking. The mean square 
displacements are calculated from non-overlapping intervals (Dickinson et al 
1994). Eq. (1) was fit to the experimental data of mean square displacements 
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(calculated from Eq. (2)) as a function of time with D and P as the only adjustable 
parameters. 
 
3.12 Cytoplasmic spreading 
 
Fibroblasts were seeded at a density of 1×104 cells per well into the 12-well 
microplates coated with fibronectin (1 µg/well) or heat-denatured BSA, as a 
negative control. Then after 3 h, cells were gently washed with PBS and fixed in 
4% formaldehyde for 15 min. After staining with 0.1% crystal violet, the cells 
were examined by microscopy. Five randomly chosen visual fields, representing 
approximately 15% of the dish surface area, were photographed and the number of 
cells was counted (at least 1000 cells). The cells were scored as either non-
spreaded or spreaded (cells that had become flattened with their total diameter 
more then twice the diameter of the nucleus) (Enserink et al. 2004).  
 
3.13 Confocal microscopy  
 
Subconfluent cells on glass coverslips were fixed for 20 min with 4% 
paraformaldehyde (Sigma) in PBS containing 0.9mM calcium and 0.5mM 
magnesium (PBS CM) at room temperature, washed twice in 50mM NH4Cl in 
PBS CM and twice in PBS CM. Cells were permeabilized for 5 min in 0.5% 
Triton-X 100 (Bio-Rad) in PBS CM, washed twice, for 10 min, in 0.2% gelatin 
(Sigma) in PBS CM and then incubated for 1 h with the primary antibodies diluted 
in 0.5% BSA (Sigma) in PBS. After three washes with 0.2% gelatine, cells were 
incubated for 20 min with the appropriate rhodamine- or fluorescein-tagged goat 
anti-mouse or anti-rabbit secondary antibody (Jackson ImmunoResearch, West 
Grove, PA), diluted 1:50 in 0.5% BSA in PBS. After final washes with PBS, the 
coverslips were mounted on a microscope slide using a 50% solution of glycerol in 
PBS and examined with a Zeiss LSM 510 version 2.8 SP1 Confocal System. The 
experiments were done with or without treatment with 30 μM PD98059. 
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4. RESULTS AND DISCUSSION 
 
 
4.1 Ped/Pea-15 effect on wound healing in vivo. 
 
In order to asses the role of Ped/Pea-15 during skin wound healing, full thikness 
wound were performed on the back of TgPED and Wt mice and several wound 
healing parameters were evaluated to follow the repair process. At 4 days after a 
dorsal incision, the distance between the wound edges was about 3-fold higher in 
TgPED mice compared to their respective Wt littermates (Table 1). Also, after 6 
days, a complete closure of the wound was observed in all Wt while not in TgPED 
mice (data not shown).  TgPED mice also presented significantly reduced 
granulation tissue formation as compared to Wt (Table 1). Histological exam of 
the wounded skin revealed a significant reduction in the skin fibroblasts content 
and a comparable reduction of collagen fibres in the PEDTg specimens, compared 
to those observed in the Wt. Wounded skin of TgPED mice also exhibited an 
increased detection of infiltrated inflammatory cells which probably contributes to 
the inhibition of healing progression (Table 1).  
 
Table 1: Assessment of wound healing parameters in Wt and TgPED mice 3 days 
post-wounding. 
 
4.2 In vivo evaluation of mice inflammatory state 
 
The first stage of the wound healing process is the inflammatory response to the 
hurt damage and the inflammatory cytokines produced at this moment are 
important to sustain the tissue repair (Acosta et al 2008). Then, to understand if 
Ped/Pea-15 overexpression contributes at the impaired wound healing observed in 
TgPED mice since the first stage of the repair process, plasma levels of several 
inflammatory cytokines were measured at 24 h after the dorsal incision of mice. 
Between the cytokines detected, IL-6, Eotaxin, INF-γ, MCP-1, MIP-1α, MIP-1β, 
TNF-α were increased in the plasma of TgPED mice compared to Wt littermates, 
Genotype 
Epidermal 
closure 
(mm) 
Granulation 
tissue  
thickness 
(%) 
Collagen 
fibres 
production 
Activated 
fibroblasts 
content 
 
Infliltrated  
cells content 
Wt 0.6±0.6 70 1.4±0.7 1.6±1 1±0.9 
 
TgPED 
 
1.7±1.4 
(p<0.001) 
40 
(p<0.001) 
0.6±0.9 
(p<0.001) 
0.9±1 
(p<0.01) 
1.5±1.3 
(p<0.01) 
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while the concentration of IL-12 results reduced (Table 2). This altered 
inflammatory state was in agreement with the increased infiltrated inflammatory 
cells observed in the skin byopsies of TgPED mice and may contribute at least in 
part to the reduced granulation tissue, collagen fibres production and reduced 
fibroblast content detected in the skin speciment.  
 
Table 2: Assessment of cytokine expression in Wt and TgPED mice 3 days post-
wounding. 
 
4.3 Assessment of angiogenic response in mice skin 
 
The aim of this experiment was to replicate the angiogenic response that occurs in 
the wound healing process. In these pathological conditions angiogenesis develops 
in response to an imbalance of positive and negative effectors that result in a 
gradient of positive angiogenic stimuli, with the direction of initial endothelial 
sprouting occurring along the axis of this gradient (Galkowska 2006). We used the 
angioreactor containing a reconstituted extracellular matrix enriched or not with 
pro-angiogenic factors to stimulate a neo-angiogenic response. Angioreactors were 
implanted in the back of each mouse. At 9 days after implantation, angioreactors 
were dissected from Wt and TgPED mice and visually inspected for angiogenesis. 
For both Wt and TgPED mice the angiogenic response was observed only in the 
FGF -2/VEGF-containing angioreactors. However, the extent of this response was 
significantly reduced in TgPED mice compared to controls (Figure 5).  
 
4.4 Effect of Ped/Pea-15 on endothelial cells migration and tube formation 
 
Angiogenesis, the biological process leading to the formation of new blood 
vessels, is a process including endothelial cells (EC) proliferation, migration and 
formation of new capillaries (Hanahan and Folkman 1996). In order to better 
clarify the angiogenc response in mice overexressing Ped/Pea-15, endothelial  
Genotype Eotaxin 
(pg/ml) 
IL-6 
(pg/ml) 
INF-γ 
(pg/ml) 
MCP-1 
(pg/ml) 
TNF-α 
(pg/ml) 
IL-12 
(pg/ml) 
MIP1-α 
(pg/ml) 
MIP1-β 
(pg/ml) 
Wt 918 64 110 382 2222 222 299 194 
 
TgPED 
 
1554 
(p<0.05) 
424 
(p<0.05) 
160 
(p<0.05) 
657 
(p<0.01) 
3214 
(p<0.01) 
90 
(p<0.05) 
728 
(p<0.05) 
445 
(p<0.05) 
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Figure 5. Quantification of DIVAA by FITC-dextran injection and validation of endothelial 
responses. Angioreactors are prepared and surgically implanted in mice as described in Materials 
and Methods. At 9 day after implantation, responses in both FGF-2  and VEGF (500 ng/ml) 
containing Matrigel and Matrigel without angiogenic factors, as indicated, are determined by 
fluorescence quantitation of FITC-dextran. Results are expressed as relative fluorescence units of 
FITC-dextran. Results of three independent experiments were shown. Asterisks denote statistically 
significant differences (*p<0.05). 
 
cells from TgPED and Wt mice were isolated. Cells were subjected to scratch 
wound healing assay and to matrigel assay to measure cell migration and tube 
formation ablity respectively. Our results showed that TgPED EC have an 
impaired migration ability compared to those isolated from Wt mice (Figure 6). 
Furthermore matrigel assays indicated also a reduction in the capillary-like tube 
formation than those of Wt EC (Figure 7).  
                            
Figure 6. Wound healing in cultured endothelial cells from TgPED mice.  
Confluent monolayers of endothelial cells from Wt and TgPED mice were subjected to scratch  
wound healing assays, as described in Materials and Methods. Healing was calculated as described 
in Materials and Methods. Bars represent the means ± SD of triplicate determination in four 
independent experiments. Asterisks denote statistically significant differences (***p<0.001). 
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Figure 7. Capillary-like tube formation of endothelial cells isolated from TgPED and Wt 
mice. A) Representative images of capillary-like tube formation in endothelial cells from TgPED 
and Wt mice on Matrigel after 8 days of culture. B) Statistical analysis of tube formation by 
counting all branches in three randomly chosen fields from each well. The experiment was repeated 
three times. Asterisks denote statistically significant differences (**p<0.01). 
 
4.5 Effect of Ped/Pea-15 on fibroblasts involved in the wound healing 
 
The components of the granulation tissue include fibroblasts, collagen (produced 
by fibroblasts) and blood vessels.  In the wound healing process, fibroblasts 
produce the collagen-based ECM and help the reapproximate of the wound edges 
through their contractile properties (Lawrence 1998). We study the wound closure 
in skin fibroblasts isolated from TgPED mice and in their Wt littermates. 
Confluent monolayers of cells were scratched and images were taken at 0 and 24 
hours after wounding (Figure 8A). The wound closure was significantly decreased 
in TgPED fibroblasts compared to controls (Fig. 8B). To determine whether the 
effect of ped/pea-15 was due to alteration of cell proliferation, scratch wound 
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healing assays were also performed in the presence of 10 µg/ml mitomycin C, an 
irreversible inhibitor of mitosis. Treatment with mitomycin C decreased the wound 
closure rate in fibroblasts of both genotypes. However, the extent of closure of 
TgPED fibroblasts was still reduced compared to controls (Figure 8B).  
 
….A 
    B               
 
                          
 
Figure 8. Wound healing in cultured fibroblasts from TgPED mice.  
A) Confluent monolayers of fibroblasts from Wt and TgPED mice were subjected to scratch wound 
healing assays, as described in Materials and Methods. Phase contrast microscopy images of 
cultured fibroblasts from TgPED mice and their Wt controls. B) Scratch assays were performed in 
the absence or in the presence of 10 µg/ml Mitomycin C, as indicated. Healing was calculated as 
described in Materials and Methods. Bars represent the means ± SD of triplicate determination in 
four independent experiments. Asterisks denote statistically significant differences (**p<0.01). 
 
Moreover, no difference between Wt and TgPED fibroblasts was detected in 
thymidine incorporation experiments (data not shown), suggesting that ped/pea-15 
effect on wound closure was not due to changes in cell proliferation. 
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4.6 Direct evaluation of fibroblast motility by time-lapse microscopy (TLM)  
 
Fibroblast motility was then assessed by quantitative analysis of images acquired 
in TLM experiments (see Materials and Methods) following the scratch and 
images were recorded with a time interval of 10 min for 24 h. Wound closure was 
visually almost complete in 24 h for Wt cells, whereas TgPED fibroblasts were 
lagging behind. In agreement with the striking difference in wound closure rate, 
TgPED fibroblasts exhibited a significantly lower average velocity (Table 3). 
Moreover, cell trajectories were reconstructed by the cell tracking image analysis 
(see Materials and Methods). In both Wt (Fig. 10A) and TgPED (Fig. 10B) 
fibroblasts, the trajectories showed a random orientation being uniformly 
distributed in space (i.e., no preferential direction of motion can be distinguished). 
However, more extended cell trajectories were detected in Wt compared to TgPED 
fibroblasts (Fig. 10A-B). The mean square displacements <d2(t)> of the two 
populations were calculated from the cell centers of mass at each time (see Eq. 2 in 
Materials and Methods). The <d2(t)> values, which are representative of cell 
migration by random diffusion, were about 2-fold higher in Wt fibroblasts. 
Accordingly, the values of D (diffusion coefficient) and P (persistence time) were 
about 2-fold higher in Wt compared to TgPED fibroblasts (Table 3). 
 
Table3: Assessment of motility parameters in fibroblasts from Wt and TgPED mice 
Genotype Velocity (µm/min) 
D 
(µm2/min) 
P 
(min) 
Wt 0.9±0.08 8.3±2.7 332±75 
TgPED 0.5±0.09 (p<0.01) 
3.9±1.2 
(p<0.01) 
143±25 
(p<0.01) 
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Figure 9. Fibroblast trajectory analysis and mean square displacements. A direct analysis of 
cell trajectories is used to characterize the motion of Wt (A) and TgPED fibroblasts (B). The 
trajectory of each cell is represented by the sequence of the cell centre of mass positions translated 
to start from the same origin. To quantitatively assess cell movement, the mean square 
displacements (C) are calculated for a population of 40 cells tracked for 16 h by using Manual Cell 
Tracking as described in Experimental procedures      
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4.7 Ped/Pea-15 effect on cell adhesion, spreading and cytoskeleton 
organization  
 
Fibroblast motility is dependent on cell ability to adhere to substrate and to 
transfer into the cytoplasm the signal that induces the cytoskeleton reorganization 
(Ridley et al 2003; Arnaout et al 2007). TgPED fibroblasts showed no significant 
difference in adhesion compared to the controls (data not shown). Moreover, after 
3 h plating on fibronectin, about 60% of Wt cells exhibited a spread cytoplasm. By 
contrast, the number of spread cells was about 30% for TgPED (Figure 10).  
 
                       
Figure 10. Cytoplasmic spreading in Wt and TgPED fibroblasts. Fibroblasts from Wt and 
TgPED mice were subjected to spreading assays. After 3h plating on fibronectin, cytoplasmic 
spreading was quantified by light microscope after staining with crystal violet as described in 
Materials and Methods. Bars represent the means ± SD of three independent determinations in 
triplicate. Asterisks denote statistically significant differences (**p<0.01) 
 
To analyze actin cytoskeleton and focal adhesion plaques organization, Wt and 
TgPED fibroblasts were stained with rhodamin-conjugated phalloidin or with 
specific anti-paxillin antibodies, respectively. Clearly, the results showed that at 
least 70% of TgPED fibroblasts displayed a marked decrease of stress fibres and 
focal adhesion plaques compared to controls (Figure 11). 
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Figure 11. Cytoskeleton organization in Wt and TgPED fibroblasts. Immunofluorescence 
analysis was performed as described in Materials and Methods. Focal adhesion plaques formation 
were investigated by immunostaining with specific anti-paxillin antibody. Stress fibers 
organization were detected by rhodaminate-phalloidin staining. The experiment was repeated four 
times with similar results. A sample image is shown.  
 
4.8 Ped/Pea-15 effect on RhoA activity and subcellular distribution. 
 
RhoA-GTPase is a protein that plays a major role in stress fibres organization and 
focal adhesion plaque formation in the cytoplasm (Huvenners et al 2009). When 
released from Rho GDP dissociation inhibitors (GDIs), Rho-GTPases are targeted 
to the plasma membrane, where its activation cycle is regulated by guanine-
exchange factors (GEFs) that promote GTP loading and activation of Rho-
GTPases (Raftopoulou et al 2004). RhoA activity was assessed in pull down assay 
by measurement of the levels of active GTP bound protein. In TgPED fibroblasts 
the levels of acive RhoA were decreased with no change in RhoA expression 
compared to Wt cells (Figure 12A). Moreover, RhoA membrane localization was 
markedly decreased in TgPED fibroblasts compared to control cells (Figure 12B). 
Consistently, RhoA cytosolic detection was much stronger in TgPED than in Wt 
fibroblasts, suggesting an aberrant localization of the protein. 
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Figure 12. RhoA activity and localization in fibroblasts from Wt and TgPed fibroblasts. A) 
Cell lysates were obtained from Wt and TgPED fibroblasts as described in Materials and Methods. 
Pull-down assays with GST-Rhotekin were performed and analyzed by Western Blot. 
Densitometry for pulled-down RhoA-GTP was normalized to the amount of total RhoA. The 
results are presented as percentage of bound respect to total level of protein. Data are mean of four 
independent experiments. Asterisks denote statistically significant differences (**p<0.01). B) 
Cytosolic and membrane fractions of Wt and TgPED fibroblasts were obtained as described in 
Materials and Methods. Western blot with anti-RhoA, β-actin and IGF-1 receptor β -subunit 
antibodies was performed. Autoradigraphs representative of four  independent experiments are 
shown.  
 
4.9 Ped/Pea-15 effect on ERK 1/2 activation and function in wound healing 
alteration 
 
It has been previously demonstrated that ped/pea-15 increased activation of 
ERK1/2 in CHO cells (Ramos et al. 2000). We have therefore tested ERK1/2 
phosphorylation in Wt and TgPED fibroblasts. As expected, ERK1/2 activation 
was increased in TgPED fibroblasts compared with Wt fibroblasts (Figure 13A). 
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Moreover ped/pea-15 overexpression increased ERK1/2 cytosolic localization in 
TgPED fibroblasts compared to the control cells (Figure 13B).  
 
                    
 
Figure 13. Evaluation of ERK 1/2 activation by PED/PEA-15 in Wt and TgPED fibroblasts. 
A) Cells were treated with PD98059 as described in Materials and Methods and solubilized. 
Western blot with with anti-phospho-ERK1/2 and ERK1/2 antibodies.was performed and 
autoradiographs were subjected to densitometric analysis. B) Cytosolic and membrane fractions of 
Wt and TgPED fibroblasts were obtained in the absence or in the presence of 30 µM PD98059, as 
described in Materials and Methods. Western blot with anti-ERK1/2, β-actin and IGF-1 receptor β-
subunit antibodies was performed. All the blots shown are representative of four independent 
experiments. 
 
To assess whether ERK1/2 hyperactivation could be responsible for wound closure 
and spreading alterations as well as for the decreased RhoA activation, 
rearrangement of RhoA localization and organization of cytoskeleton structures, 
fibroblasts from both Wt and TgPED mice were treated with 30 µM PD98059 (an 
inhibitor of the MEK-ERK1/2 pathway). At this concentration PD98059 did not 
affect both proliferation and morphology of Wt and TgPED fibroblasts (data not 
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shown), as well as ERK1/2 localization (Figure 13B). Nevertheless it was able to 
reduce ERK 1/2 phosphorylation in both cellular types (Figure 13A). Treatment 
with PD98059 increased wound closure in Wt fibroblasts and almost completely 
rescued wound closure in TgPED fibroblasts (Figure 14).  
 
                    
 
Figure 14. Effect of PKC and ERK inhibitors on in vitro wound healing. Confluent monolayers 
of fibroblasts from Wt and TgPED mice were subjected to scratch assays, as described in Materials 
and Methods. The scratch assays were performed in culture medium alone or added with 5 µM 
BDM or 30 µM PD98059, as indicated. Healing was calculated as described in Materials and 
Methods. Bars represent the means ± SD of triplicate determination in four independent 
experiments. Asterisks denote statistically significant differences (*p<0.05; **p<0.01; p<0.001).  
 
At variance, in both Wt and TgPED fibroblasts, almost no effect was elicited by 
treatment with 5 µM bisindolylmaleimide (BDM), wich inhibited PKC activity in 
both cell type (data not shown). Moreover, treatment with PD98059 completely 
reverted the effect of PED/PEA-15 on spreading (Figure 15A) and determined a 
substantial rescue of stress fibres and focal adhesion plaques in about 90% of 
TgPED fibroblasts, compared to the controls (Figure 15B). Similarly, PD98059 
treatment restored RhoA activity (data not shown) and plasma membrane content 
in TgPED fibroblasts to the levels observed for Wt fibroblasts (Fig. 15C). 
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Figure 15. Effect of PD98059 on spreading, cytoskeleton organization and RhoA localization. 
A) Cytoplasmic spreading was quantified in TgPED fibroblasts pre-incubated in the absence or in 
the presence of 30 µM PD98059, as indicated, as described in Mterials and Methods. Bars 
represent the means ± SD of three independent determinations in triplicate. Asterisks denote 
statistically significant differences (**p<0.01; ***p<0.001). B) Immunoflorescence analysis was 
performed in Wt and TgPED fibroblasts incubated with 30 µM PD98059. Focal adhesion plaques 
formation was investigated by immunostaining with specific anti-paxillin antibody. Stress fibers 
were detected by rhodaminate-phalloidin staining. The experiment was repeated four times with 
similar results. A sample image is shown. C) Cytosolic and membrane fractions of Wt and TgPED 
fibroblasts cultured in the absence or in the presence of 30 µM PD98059, as indicated, were 
obtained as described in Materials and Methods, subjected to SDS-PAGE and immunoblotted with 
anti-RhoA, β-actin and IGF-1 receptor β-subunit antibodies. Blots were revealed by ECL and 
autoradiography. The blots shown are representative of four independent experiments 
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4.10 Ped/Pea-15 depletion increased fibroblast spreading and wound closure  
 
To further address the role of ped/pea-15 in the regulation of cellular motility, we 
used fibroblasts from ped/pea-15 null mice (KO). These animals have been 
previously characterized and reported (Miele et al. 2007) and feature no 
PED/PEA-15 expression in skin fibroblasts (data not shown). Importantly, after 3 
h plating on fibronectin, cytoplasmic spreading was increased by about 30% 
compared to control cells (Figure 16A). Likewise, the abilty to recolonize the 
wounded area was also increased in ped/pea-15 null fibroblasts (Figure 16B). 
Furthermore, wound closure was almost complete after 16 h in KO fibroblasts, 
while it occurred at least after 24 h in control mice.  
                              
                            
 
Figure 16. Cytoplasmic spreading and in vitro wound healing in ped/pea-15 null fibroblasts. 
A) Fibroblasts from Wt and ped/pea-15 null mice were subjected to spreading assays. After 3h, 
cytoplasmic spreading on fibronectin was quantified by light microscope after staining with crystal 
violet as described in Experimental procedures. Bars represent the means ± SD of three 
independent determinations in triplicate. Asterisks denote statistically significant differences 
(**p<0,01). B) Confluent monolayers of fibroblasts from Wt and ped/pea-15 null mice were 
subjected to scratch assays, as described in Materials and Methods. Healing was calculated as 
described in Experimental procedures. Bars represent the means ± SD of triplicate determination in 
four independent experiments. Asterisks denote statistically significant differences (**p<0.01). 
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Finally we have also examined wound healing in KO mice. In these mice the 
distance between the wound edges was about 2-fold lower compared to their 
respective Wt littermates. Moreover, the content of activated fibroblasts was 
significantly increased in KO mice (Table 3).  
 
Table 3: Assessment of wound healing in KO mice 4 days post-wounding. 
 
 
 
 
 
 
 
Genotype 
Epidermal 
closure 
(mm) 
Activated 
fibroblasts 
content 
Wt 0.8±0.2 1.4±1 
KO 
 
0.4±0.1 
(p<0.05) 
 
1.9±0.3 
(p<0.05) 
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5. CONCLUSIONS 
 
Transgenic mice overexpressing PED/PEA-15 (TgPED) to levels comparable to 
those occurring in patients with type 2 diabetes, display altered glucose tolerance 
and impaired insulin secretion. Here, we show that TgPED mice display also an 
impaired skin wound healing when subjected to dorsal incision and that their 
phenotype reflects, at least in part, the phenotype of chronic non-healing ulcers of 
diabetic patients. 
The analysis of all stages reveald that the process of skin wound healing is alterd 
in each phase in the TgPED mouse model: inflammation, granulation tissue 
formation and re-epithelization. Similar as the human pathological ulcers, the 
reapir process which occurs after injury is stalled in the inflammatory phase. This 
is confirmed by the increased infiltrate of inflammatory cells in the TgPED mice 
skin specimens and by the increase in the serum concentration of some 
inflammatory cytokines. Persistently high levels of TNF-α and related cytokines 
as IL-6, Eotaxin, INF-γ, MCP-1, MIP1-α and MIP1-β adversely affect the growth, 
the viability and the functions of cell types necessary for appropriate formation of 
a healthy extracellular matrix, such as endothelial cells and fibroblasts (Acosta et 
al. 2008). Indeed in TgPED mice we found a decreased growth of the granulation 
tissue, a tissue that come from endothelial cells and fibroblasts migration and 
proliferation in the wound bed. Moreover we found a reduced capillary tube 
formation, a reduction in fibroblasts content and a collagen fibres production. 
Thus, likewise diabetic patients, TgPED mice have impaired fibroblast migration 
and insufficient angiogensis to support the collagen synthesis necessary for mature 
granulation and subsequent re-epithelialization (Falanga 2005). Then, in TgPED 
mice the altered wound healing may be due to the high levels of inflammatory 
cytokines and in particular TNF-α. This is consistent with recent observation 
indicating that low concentrations of TNF-α stimulate fibroblasts to repopulate a 
wound space, enhance collagen production, promote angiogenesis, accelerate 
reepithelialization with significantly less neutrophil and macrophage infiltration, 
and decrease gene expression of several inflammatory molecules, while at high 
levels of TNF-α all these processes are impeded (Berrientos et al. 2008; Weinstein 
and Kirsner 2010). Then we focused our attention on the study of endothelial cells 
and fibroblasts isolated from TgPED and Wt mice. Both cells type showed a 
migratory defect. This is in agreement with the results obtained with the in vivo 
studies. It should be noticed that TgPED mice displayed reduced glucose tolerance 
and impaired insulin sensitivity (Vigliotta et al. 2004). Thus it is possible that 
metabolic abnormalities may confer to the isolated cells, phenotypes reminiscent 
of the “in vivo” metabolic milieu. Indeed metabolic memory is generally 
recognized to participate to the pathogenesis of diabetes and its complications 
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(Villeneuve and Natarajan 2010). However, cells isolated from TgPED mice live 
for several generations in culture, independently of the metabolic status, raising 
the possibility that PED/PEA-15 may directly regulate the motility phenoyipe. In 
support of this latter hypothesis, it should be mentioned that cells in which 
PED/PEA-15 cDNA has been overexpressed display defects in cellular adhesion 
and integrin signalling (Krueger et al 2005). Furthermore we have also 
demonstrated that in scratch wound healing assay, closure was accelerated in 
fibroblasts isolated from ped/pea-15 null mice.  
Collectively, these data suggest that PED/PEA-15 is able to impair skin wound 
healing, in particular modulating the functions of cells that are involved in the 
repair process, and open the way for future investigations on its role in diabetic 
complications.   
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